Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Tomosyn interacts with the SUMO E3 ligase PIASγ.

Geerts CJ, Jacobsen L, van de Bospoort R, Verhage M, Groffen AJ.

PLoS One. 2014 Mar 10;9(3):e91697. doi: 10.1371/journal.pone.0091697. eCollection 2014.

PMID:
24614299
[PubMed - in process]
Free PMC Article
2.

PIAS3 promotes homology-directed repair and distal non-homologous end joining.

Liu S, Fan Z, Geng Z, Zhang H, Ye Q, Jiao S, Xu X.

Oncol Lett. 2013 Oct;6(4):1045-1048. Epub 2013 Jul 17.

PMID:
24137461
[PubMed]
Free PMC Article
3.

SUMOylation of p53 mediates interferon activities.

Marcos-Villar L, Pérez-Girón JV, Vilas JM, Soto A, de la Cruz-Hererra CF, Lang V, Collado M, Vidal A, Rodríguez MS, Muñoz-Fontela C, Rivas C.

Cell Cycle. 2013 Sep 1;12(17):2809-16. doi: 10.4161/cc.25868. Epub 2013 Aug 5.

PMID:
23966171
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation.

O'Rourke JG, Gareau JR, Ochaba J, Song W, Raskó T, Reverter D, Lee J, Monteys AM, Pallos J, Mee L, Vashishtha M, Apostol BL, Nicholson TP, Illes K, Zhu YZ, Dasso M, Bates GP, Difiglia M, Davidson B, Wanker EE, Marsh JL, Lima CD, Steffan JS, Thompson LM.

Cell Rep. 2013 Jul 25;4(2):362-75. doi: 10.1016/j.celrep.2013.06.034. Epub 2013 Jul 18.

PMID:
23871671
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

SUMOylation of mouse p53b by SUMO-1 promotes its pro-apoptotic function in ovarian granulosa cells.

Liu XM, Yang FF, Yuan YF, Zhai R, Huo LJ.

PLoS One. 2013 May 16;8(5):e63680. doi: 10.1371/journal.pone.0063680. Print 2013.

PMID:
23696846
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.

Xia Y, Yang W, Bu W, Ji H, Zhao X, Zheng Y, Lin X, Li Y, Lu Z.

J Biol Chem. 2013 Jul 5;288(27):19321-9. doi: 10.1074/jbc.M113.475442. Epub 2013 May 15.

PMID:
23678002
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

PML Degradation: Multiple Ways to Eliminate PML.

Rabellino A, Scaglioni PP.

Front Oncol. 2013 Mar 22;3:60. doi: 10.3389/fonc.2013.00060. eCollection 2013.

PMID:
23526763
[PubMed]
Free PMC Article
8.

UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.

Oh Y, Chung KC.

J Biol Chem. 2013 Mar 29;288(13):9102-11. doi: 10.1074/jbc.M112.438234. Epub 2013 Feb 12.

PMID:
23404503
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

SUMO modification of menin.

Feng ZJ, Gurung B, Jin GH, Yang XL, Hua XX.

Am J Cancer Res. 2013;3(1):96-106. Epub 2013 Jan 18.

PMID:
23359867
[PubMed]
Free PMC Article
10.

cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Lau R, Niu MY, Pratt MA.

Cell Cycle. 2012 Nov 1;11(21):4009-19. doi: 10.4161/cc.22223. Epub 2012 Oct 3.

PMID:
23032264
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.

Sudharsan R, Azuma Y.

J Cell Sci. 2012 Dec 1;125(Pt 23):5819-29. doi: 10.1242/jcs.110825. Epub 2012 Sep 12.

PMID:
22976298
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Therapeutic strategies for head and neck cancer based on p53 status.

Ota I, Okamoto N, Yane K, Takahashi A, Masui T, Hosoi H, Ohnishi T.

Exp Ther Med. 2012 Apr;3(4):585-591. Epub 2012 Feb 3.

PMID:
22969933
[PubMed]
Free PMC Article
13.

Functional reconstitution of a tunable E3-dependent sumoylation pathway in Escherichia coli.

O'Brien SP, DeLisa MP.

PLoS One. 2012;7(6):e38671. doi: 10.1371/journal.pone.0038671. Epub 2012 Jun 12.

PMID:
22701689
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The SUMO pathway promotes basic helix-loop-helix proneural factor activity via a direct effect on the Zn finger protein senseless.

Powell LM, Chen A, Huang YC, Wang PY, Kemp SE, Jarman AP.

Mol Cell Biol. 2012 Jul;32(14):2849-60. doi: 10.1128/MCB.06595-11. Epub 2012 May 14.

PMID:
22586269
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

An acetylation switch regulates SUMO-dependent protein interaction networks.

Ullmann R, Chien CD, Avantaggiati ML, Muller S.

Mol Cell. 2012 Jun 29;46(6):759-70. doi: 10.1016/j.molcel.2012.04.006. Epub 2012 May 10.

PMID:
22578841
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

Rabellino A, Carter B, Konstantinidou G, Wu SY, Rimessi A, Byers LA, Heymach JV, Girard L, Chiang CM, Teruya-Feldstein J, Scaglioni PP.

Cancer Res. 2012 May 1;72(9):2275-84. doi: 10.1158/0008-5472.CAN-11-3159. Epub 2012 Mar 9.

PMID:
22406621
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.

Stindt MH, Carter S, Vigneron AM, Ryan KM, Vousden KH.

Cell Cycle. 2011 Sep 15;10(18):3176-88. Epub 2011 Sep 15.

PMID:
21900752
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity.

Song YJ, Lee H.

Mol Cells. 2011 Sep;32(3):221-6. doi: 10.1007/s10059-011-1020-8. Epub 2011 Jun 27.

PMID:
21717107
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.

Sun Y, Perera J, Rubin BP, Huang J.

J Biol Chem. 2011 May 27;286(21):18623-32. doi: 10.1074/jbc.M110.176693. Epub 2011 Mar 24.

PMID:
21454665
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.

Yan W, Zhang Y, Zhang J, Liu S, Cho SJ, Chen X.

J Biol Chem. 2011 May 20;286(20):17478-86. doi: 10.1074/jbc.M111.231639. Epub 2011 Mar 29.

PMID:
21454520
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk